Chemomab Therapeutics LTD. (CMMB) — SC 13D/A Filings
All SC 13D/A filings from Chemomab Therapeutics LTD.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Adi Mor Amends Chemomab Therapeutics Stake
— Nov 29, 2024 Risk: medium
Adi Mor has amended their Schedule 13D filing for Chemomab Therapeutics Ltd. on November 29, 2024. This filing indicates a change in the beneficial ownership of -
OrbiMed Files 13D/A Amendment for Chemomab Therapeutics
— Sep 16, 2024 Risk: medium
OrbiMed Israel BioFund GP Limited Partnership, through its group members Carl L. Gordon and Erez Chimovits, has filed an amendment (No. 4) to its Schedule 13D c -
OrbiMed Files 13D/A Amendment for Chemomab Therapeutics
— Mar 11, 2024 Risk: medium
OrbiMed Israel BioFund Limited Partnership, along with Carl L. Gordon and Erez Chimovits, filed an amendment (No. 3) to their Schedule 13D on March 11, 2024, co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX